Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Bristol-Myers Squibb
ImmunityBio, Inc.
University of Pittsburgh
Incyte Corporation
Molecular Templates, Inc.
Fate Therapeutics
Incyte Corporation